NDC 0169-2201

NovoLog Mix 70/30

Insulin Aspart

NovoLog Mix 70/30 is a Subcutaneous Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Aspart.

Product ID0169-2201_3fdc375f-3c78-4a91-9bcd-092f51332b41
NDC0169-2201
Product TypeHuman Prescription Drug
Proprietary NameNovoLog Mix 70/30
Generic NameInsulin Aspart
Dosage FormInjection, Suspension
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2002-09-11
Marketing CategoryBLA /
Application NumberBLA021172
Labeler NameNovo Nordisk
Substance NameINSULIN ASPART
Active Ingredient Strength100 [iU]/mL
Pharm ClassesInsulin [CS],Insulin Analog [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0169-2201-25

5 SYRINGE, PLASTIC in 1 CARTON (0169-2201-25) > 3 mL in 1 SYRINGE, PLASTIC
Marketing Start Date2021-07-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "NovoLog Mix 70/30" or generic name "Insulin Aspart"

NDCBrand NameGeneric Name
0169-2200NovoLog Mix 70/30insulin aspart
0169-2201NovoLog Mix 70/30insulin aspart
0169-3685NovoLog Mix 70/30insulin aspart
0169-3696NovoLog Mix 70/30insulin aspart
50090-2272NovoLog Mix 70/30NovoLog Mix 70/30
50090-2273NovoLog Mix 70/30NovoLog Mix 70/30
70518-2119NovoLog Mix 70/30NovoLog Mix 70/30
50090-4074NovoLog Mix 70/30NovoLog Mix 70/30
0169-2100NOVOLOGinsulin aspart
0169-2101NOVOLOGinsulin aspart
0169-3303NOVOLOGinsulin aspart
0169-6338NOVOLOGinsulin aspart
0169-6339NOVOLOGinsulin aspart
0169-7501NOVOLOGinsulin aspart
50090-1664NOVOLOGinsulin aspart
50090-1665NovoLoginsulin aspart
50090-1678NOVOLOGinsulin aspart

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.